SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,322,924 | -8.4% | 4,425,732 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $111,681,233 | +33.7% | 4,259,391 | +31.3% | 0.00% | +50.0% |
| Q1 2023 | $83,501,384 | -3.4% | 3,244,032 | -2.4% | 0.00% | -33.3% |
| Q4 2022 | $86,476,435 | +7.4% | 3,324,738 | +17.8% | 0.00% | 0.0% |
| Q3 2022 | $80,492,000 | +24.8% | 2,821,344 | +7.7% | 0.00% | +50.0% |
| Q2 2022 | $64,489,000 | -50.4% | 2,619,457 | +13.7% | 0.00% | -50.0% |
| Q1 2022 | $129,998,000 | -11.2% | 2,303,279 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $146,375,000 | -5.5% | 2,361,652 | -3.3% | 0.00% | 0.0% |
| Q3 2021 | $154,868,000 | -24.4% | 2,441,178 | -1.8% | 0.00% | -33.3% |
| Q2 2021 | $204,897,000 | +22.7% | 2,486,323 | +9.6% | 0.01% | +20.0% |
| Q1 2021 | $166,969,000 | +2.5% | 2,269,538 | +1.0% | 0.01% | 0.0% |
| Q4 2020 | $162,890,000 | +156.0% | 2,246,143 | +68.3% | 0.01% | +150.0% |
| Q3 2020 | $63,623,000 | +25.1% | 1,334,643 | +10.2% | 0.00% | 0.0% |
| Q2 2020 | $50,847,000 | +185.7% | 1,210,670 | +83.7% | 0.00% | +100.0% |
| Q1 2020 | $17,795,000 | -27.9% | 659,095 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $24,670,000 | +998.9% | 640,961 | +518.8% | 0.00% | – |
| Q3 2019 | $2,245,000 | – | 103,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |